Navinta Llc, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Apothecon- Your trusted partner for APIs & HPAPIs// Emerging leader in therapeutic generic drugs.
One of their notable products is PHENOXYBENZAMINE HYDROCHLORIDE USP, with a corresponding US DMF Number 31746.
Remarkably, this DMF maintains an Active status since its submission on December 28, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 16, 2019, and payment made on March 05, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II